Proteomics International Laboratories Limited (PIQ.AX)

0.9000 0.0000 (0.00%) At close: 03:58PM AEST

Proteomics International Laboratories Limited

QEII Medical Centre
QQ Block 6 Verdun Street Nedlands
Perth, WA 6009
Australia
61 8 9389 1992
https://www.proteomics.com.au

Sector(s): Healthcare
Industry: Biotechnology
Full Time Employees: 

Key Executives

Name	Title	Pay	Exercised	Year Born
Dr. Richard John Lipscombe M.A., MA (Oxford), Ph.D., Ph.D., (London)	Co-Founder, MD & Director	442k	N/A	N/A
Ms. Jacqueline Gray	Chief Financial Officer	261.95k	N/A	N/A
Mr. John Chuck Morrison	Head of Bus. Devel.	N/A	N/A	N/A
Dr. Scott Bringans	Head of Research	N/A	N/A	N/A
Dr. Pearl Tan	Head of Logistics	N/A	N/A	N/A
Mr. Vikesh Malik	Chief Commercialisation Officer	N/A	N/A	N/A
Dr. Kirsten Peters	Head of Clinical Studies	N/A	N/A	N/A
Ms. Karen Teresa Logan ACIS, B.Com., BCom, DipAppCorpGov, F Fin, FCIS, FC	Company Sec.	N/A	N/A	N/A

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.

Description

Proteomics International Laboratories Limited operates as a medical technology company with a focus on the area of proteomics. It provides PromarkerD, a predictive test for diabetic kidney disease; and develops diagnostic tests for endometriosis and giardia. The company also offers analytical services, including specialist contract research. The company was founded in 2001 and is based in Perth, Australia.

Corporate Governance

Proteomics International Laboratories Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.